S D A Labs

ProPhase Labs is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE family of lozenges and sugar free tablets clinically proven to significantly reduce the severity and duration of the common cold. Cold-EEZE customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA approved facility to manufacture Cold-EEZE lozenges and fulfill other contract manufacturing opportunities, and a Pharma division, which conducts research in order to develop and commercialize a pipeline of patented botanical and naturally derived potential prescription drugs. ProPhase also owns 50% of Phusion Laboratories LLC ("Phusion"). Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds. The joint venture will formulate and test products to exploit market opportunities within ProPhase's robust OTC distribution channels.

Jamol Laboratories Inc, located in Emerson, NJ, offers the all-natural Ponaris nasal emollient to provide relief for a variety of nasal issues such as congestion, post nasal drip, and dryness. This effective formula, once a standard in NASA's medical space kit, contains a blend of botanical oils including pine, eucalyptus, peppermint, cajeput, and cottonseed. Since 1931, Ponaris has been a prescribable therapy for conditions like colds, sinusitis, allergic rhinitis, and epistaxis, thanks to its carefully selected mucosal lubricating and moisturizing oils treated through the exclusive J.R. iodization process. With active ingredients designed to alleviate nasal discomfort, Ponaris is a trusted solution for those seeking relief from various nasal ailments. Generated from the website

United-Guardian is a diversified company that provides research, product development, manufacturing and marketing. The company focuses on products, such as pharmaceuticals, cosmetic ingredients, health care products, medical devices and proprietary industrial products. United-Guardian has been granted more than 30 patents and has a catalog of approximately 100 products in various stages of development. The company has moved from almost exclusively emphasizing research and product development to the marketing of its proprietary product portfolio. United-Guardian has a marketing agreement with International Specialty Products, which deals with cosmetic products in the United States, Canada, Mexico, South and Central America, Europe and Asia. The company was founded in 1942 and maintains its headquarters in Hauppauge, N.Y.